111 related articles for article (PubMed ID: 20374188)
41. Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes.
Colussi G; Catena C; Novello M; Bertin N; Sechi LA
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):191-200. PubMed ID: 27692558
[TBL] [Abstract][Full Text] [Related]
42. [Blood fatty acids in the development and correction of metabolic syndrome].
Novgorodtseva TP; Denisenko YK; Antonyuk MV; Yubitskaya NS; Lobanova EG; Zhukova NV
Ter Arkh; 2016; 88(8):30-34. PubMed ID: 27636924
[TBL] [Abstract][Full Text] [Related]
43. One month of omega-3 fatty acid supplementation improves lipid profiles, glucose levels and blood pressure in overweight schoolchildren with metabolic syndrome.
García-López S; Villanueva Arriaga RE; Nájera Medina O; Rodríguez López CP; Figueroa-Valverde L; Cervera EG; Muñozcano Skidmore O; Rosas-Nexticapa M
J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1143-1150. PubMed ID: 27658130
[TBL] [Abstract][Full Text] [Related]
44. [Preventive effects of supplemental n-3 polyunsaturated fatty acids on metabolic syndromes].
Onodera M; Morita I
Nihon Rinsho; 2006 Dec; 64 Suppl 9():564-8. PubMed ID: 17458282
[No Abstract] [Full Text] [Related]
45. Omega-3 fatty acids supplementation improves endothelial function and arterial stiffness in hypertensive patients with hypertriglyceridemia and high cardiovascular risk.
Casanova MA; Medeiros F; Trindade M; Cohen C; Oigman W; Neves MF
J Am Soc Hypertens; 2017 Jan; 11(1):10-19. PubMed ID: 27876342
[TBL] [Abstract][Full Text] [Related]
46. [Effect of omega-3 fatty acids on the serum lipid profile and microcirculation in patients with metabolic syndrome and hypertensive disease].
Vasil'ev AP; Strel'tsova NN; Sekisova MA
Klin Med (Mosk); 2009; 87(4):37-41. PubMed ID: 19514319
[TBL] [Abstract][Full Text] [Related]
47. Baroreflex sensitivity and central hemodynamics after omega-3 polyunsaturated fatty acids supplementation in an animal model of menopause.
Losurdo P; Grillo A; Panizon E; Zanetti M; Bardelli M; Biolo G; Fabris B; Carretta R
Vascul Pharmacol; 2015 Aug; 71():65-9. PubMed ID: 25863292
[TBL] [Abstract][Full Text] [Related]
48. Omega-3 polyunsaturated fatty acids supplementation in patients with diabetes and cardiovascular disease risk: does dose really matter?
Tenenbaum A; Fisman EZ
Cardiovasc Diabetol; 2018 Aug; 17(1):119. PubMed ID: 30153832
[TBL] [Abstract][Full Text] [Related]
49. Moderate Dietary Supplementation with Omega-3 Fatty Acids Does Not Impact Plasma Von Willebrand Factor Profile in Mildly Hypertensive Subjects.
Bürgin-Maunder CS; Brooks PR; Hitchen-Holmes D; Russell FD
Biomed Res Int; 2015; 2015():394871. PubMed ID: 26290867
[TBL] [Abstract][Full Text] [Related]
50. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management.
Cicero AF; Ertek S; Borghi C
Curr Vasc Pharmacol; 2009 Jul; 7(3):330-7. PubMed ID: 19601857
[TBL] [Abstract][Full Text] [Related]
51. Heart rate and blood pressure in the context of nutritional and psychological analysis: a case study.
Wilczynska A; De Meester F; Singh Ram B; Bargiel-Matusiewicz K
Eur J Med Res; 2010 Nov; 15 Suppl 2():217-23. PubMed ID: 21147655
[TBL] [Abstract][Full Text] [Related]
52. Associations of plasma n-3 polyunsaturated fatty acids with blood pressure and cardiovascular risk factors among Chinese.
Huang T; Shou T; Cai N; Wahlqvist ML; Li D
Int J Food Sci Nutr; 2012 Sep; 63(6):667-73. PubMed ID: 22263527
[TBL] [Abstract][Full Text] [Related]
53. Long-Chain Polyunsaturated Fatty Acids Are Associated with Blood Pressure and Hypertension over 10-Years in Black South African Adults Undergoing Nutritional Transition.
Zec MM; Schutte AE; Ricci C; Baumgartner J; Kruger IM; Smuts CM
Foods; 2019 Sep; 8(9):. PubMed ID: 31500169
[TBL] [Abstract][Full Text] [Related]
54. Effects of Omega-3 Fatty Acids Supplementation on Serum Lipid Profile and Blood Pressure in Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Liu YX; Yu JH; Sun JH; Ma WQ; Wang JJ; Sun GJ
Foods; 2023 Feb; 12(4):. PubMed ID: 36832799
[TBL] [Abstract][Full Text] [Related]
55. The beneficial effects of omega-3 polyunsaturated fatty acids on controlling blood pressure: An umbrella meta-analysis.
Musazadeh V; Kavyani Z; Naghshbandi B; Dehghan P; Vajdi M
Front Nutr; 2022; 9():985451. PubMed ID: 36061895
[TBL] [Abstract][Full Text] [Related]
56. Effect of PUFA on patients with hypertension: a hospital based study.
Shantakumari N; Eldeeb RA; Ibrahim SA; Sreedharan J; Otoum S
Indian Heart J; 2014; 66(4):408-14. PubMed ID: 25173198
[TBL] [Abstract][Full Text] [Related]
57. Whole blood omega-3 fatty acid concentrations are inversely associated with blood pressure in young, healthy adults.
Filipovic MG; Aeschbacher S; Reiner MF; Stivala S; Gobbato S; Bonetti N; Risch M; Risch L; Camici GG; Luescher TF; von Schacky C; Conen D; Beer JH
J Hypertens; 2018 Jul; 36(7):1548-1554. PubMed ID: 29570511
[TBL] [Abstract][Full Text] [Related]
58. [Metabolic syndrome reversion by polyunsaturated fatty acids ingestion].
Campos Mondragón MG; Oliart Ros RM; Martínez Martinez A; Méndez Machado GF; Angulo Guerrero JO
Med Clin (Barc); 2013 Dec; 141(12):513-8. PubMed ID: 23522799
[TBL] [Abstract][Full Text] [Related]
59. Effects of omega 3-PUFA on plasma fibrinogen levels in hypertriglyceridemic hemodialysis patients.
Persichetti S; Maggi S; Ponzio R; Punzo G; Clemenzia G; Cottone G
Minerva Urol Nefrol; 1996 Sep; 48(3):137-8. PubMed ID: 8913077
[No Abstract] [Full Text] [Related]
60. Prehypertension and metabolic syndrome: prevention of hypertension and cardiovascular events.
Matsuura H
Hypertens Res; 2008 Jul; 31(7):1275-6. PubMed ID: 18957794
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
